← Back to Search

Breathing and Attention Training for Chronic Lower Back Pain

Phase 1 & 2
Waitlist Available
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Chronic low back pain consistent with recommendations of the NIH task force on cLBP (i.e., participants with cLBP of at least moderate impact that has persisted on more days than not over the past 3 months)
Age 18-65
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months
Awards & highlights

Study Summary

This trial is testing whether a breathing and attention training treatment can improve pain symptoms and wellbeing in people with chronic low back pain. There are two types of the treatment being tested, standard and focused.

Eligible Conditions
  • Chronic Lower Back Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Adverse Events
Treatment Satisfaction Questionnaire
Secondary outcome measures
Change in Pain Intensity

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Focused Breathing and Attention TrainingExperimental Treatment1 Intervention
The focused BAT is similar to the standard BAT in most ways but includes extra instructions to help focus and alter breathing patterns. Participants will practice focused BAT once a day for 15 minutes for 5 days in a row.
Group II: Standard Breathing and Attention TrainingActive Control1 Intervention
The standard breathing and attention training (BAT) includes guided instructions on deep breathing and relaxation. Participants will practice standard BAT once a day for 15 minutes for 5 days in a row.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Breathing and Attention Training
2021
Completed Phase 2
~30

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,338 Previous Clinical Trials
715,327 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation take into consideration participants below the age of seventy-five?

"This study requires the enrollment of individuals aged 18 to 65. However, there are extra medical trial opportunities for those below and above this age bracket: 26 studies exist for minors while 344 trials target seniors."

Answered by AI

Is my candidacy suitable for this medical experiment?

"Eligibility criteria for this clinical trial stipulate that individuals must have respiratory aspiration and be aged between 18 and 65. Approximately 30 participants are required in total."

Answered by AI

Are recruitment efforts underway for this experiment?

"According to the clinicaltrials.gov platform, this research program is actively recruiting members since its initial posting on July 18th 2021 and most recent edit on May 25th 2022."

Answered by AI

What is the size of the cohort engaging in this medical trial?

"Affirmative. Per the clinicaltrials.gov website, registration for this research is still open since it was first published on July 18th 2021 and recently updated on May 25th 2022. 30 patients are required from one medical site to partake in the trial."

Answered by AI

Who else is applying?

What state do they live in?
Washington
What site did they apply to?
University of Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

What questions have other patients asked about this trial?

What do the visits consist of?
PatientReceived 1 prior treatment
~8 spots leftby Apr 2025